Sonia Sugg, MD

Portrait
Program Director, Breast Interdisciplinary Fellowship
Medical Director, Breast Health Clinic
Holden Professorship in Breast Cancer Surgery
Endocrine and Breast Oncology Surgeon
Clinical Professor of Surgery - Surgical Oncology and Endocrine Surgery

Contact Information

Primary Office: 4646 JCP
Iowa City, IA 52242
319-356-7675

Education

BA, University of Hawaii at Manoa
MD, University of California, Los Angeles

Resident, General Surgery, University of Michigan Medical Center
Fellow, Surgical Oncology, National Cancer Institute, Surgery Branch
Resident, General Surgery, University of Michigan Medical Center
Fellow, Endocrine Surgery, Mount Sinai Hospital, University of Toronto

Licensure and Certifications

Board Certified, Recertifcation - American Board of Surgery
Iowa Medical License - Iowa Board of Medicine
Diplomate of the American Board of Surgery

Publications

Spanheimer, P. M., Park, J., Askeland, R., Kulak, M., Woodfield, G., De Andrade, J., Cyr, A., Sugg, S., Thomas, A. & Weigel, R. (2014). Inhibition of RET Increases the Efficacy of Antiestrogen and Is a Novel Treatment Strategy for Luminal Breast Cancer. Clinical Cancer Research, 20(8), 2115-25. PMID: 24526731.

Ross, D., Sugg, S. (2013). Surgery in the treatment of hyperthyroidism: Indications, preoperative preparation, and postoperative follow-up.

Lizarraga, I., Sugg, S., Weigel, R. & Scott-Conner, C. (2013). Review of risk factors for the development of contralateral breast cancer. American Journal of Surgery, 206(5), 704-708. PMID: 24016706.

Sugg, S., Gurll, N. (2013). Parathyroidectomy. In C. E. Scott-Conner (Eds.) Chassin’s Operative Strategy in General Surgery. Springer.

Du, W., Fang, L., Li, M., Yang, X., Liang, Y., Peng, C., Qian, W., O'Malley, Y., Askeland, R., Sugg, S., Qian, J., Lin, J., Jiang, Z., Yee, A., Sefton, M., Deng, Z., Shan, S., Wang, C. & Yang, B. (2013). MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling. PMID: 23418360.

Spanheimer, P., Stoltze, A., Howe, J., Sugg, S., Lal, G. & Weigel, R. (2013). Do giant parathyroid adenomas represent a distinct clinical entity?. Surgery, 154(4), 714-718. PMID: 23978594.

Spanheimer, P., Stoltze, A., Howe, J., Sugg, S., Lal, G. & Weigel, R. (2013). Do giant parathyroid adenomas represent a distinct clinical entity?. Surgery.

Houston, C., Sugg, S. & Doelle, G. (2013). Elusive parathyroid carcinoma in a patient with suspected Hyperparathyroidism-Jaw Tumor Syndrome. Endocrine Society Annual Meeting.

Carr, J., Spanheimer, P., Rajput, M., Dahdaleh, F., Lal, G., Weigel, R., Sugg, S., Liao, J. & Howe, J. (2013). Discriminating pheochromocytomas from other adrenal lesions: the dilemma of elevated catecholamines. Annals of Surgical Oncology, 20(12), 3855-3861. PMID: 23884753.

Lizarraga, I., Scott-Conner, C., Muzahir, S., Weigel, R., Graham, M. & Sugg, S. (2013). Management of contralateral axillary sentinel lymph nodes detected on lymphoscintigraphy for breast cancer. Annals of Surgical Oncology, 20(10), 3317-3322. PMID: 23975295.

Maity, B., Stewart, A., O'Malley, Y., Askeland, R., Sugg, S. & Fisher, R. (2013). RGS6 functions as a novel suppressor of tumor initiation and progression in a mouse model of breast carcinogenesis. Carcinogenesis.

Spanheimer, P., Carr, J., Thomas, A., Sugg, S., Scott-Conner, C., Liao, J. & Weigel, R. (2013). The response to neoadjuvant chemotherapy predicts clinical outcome and increases breast conservation in advanced breast cancer. American Journal of Surgery, 206(1), 2-7. PMID: 23375759.

Bhama, A., Yassa, E., Wertzberger, B., Menda, Y., Lal, G., Howe, J., Weigel, R. & Sugg, S. (2012). Thyroidectomy for Thyroid Radioactive Iodine Uptake and Outcomes after Cancer. American Association of Endocrine Surgeons.

O'Malley, Y., Lal, G., Howe, J., Weigel, R. & Sugg, S. (2012). Invasion in Follicular Thyroid Cancer (FTC) Cell Lines is Mediated by EphA2 and pAkt. American Association of Endocrine Surgeons.

Lal, G., Sugg, S. (2012). Hyperthyroidism. In Sipple , Chen (Eds.) Handbook of Endocrine Surgery. World Scientific Publishing..

Lal, G., Groff, M., Howe, J., Weigel, R., Sugg, S. & Lynch, C. (2012). Risk of Subsequent Primary Thyroid Cancer after Another Malignancy: Latency Trends in a Population-based Study. Annals of Surgical Oncology, 19(6), 1887-1896. PMID: 22227921.

Dirksen, J., Scott-Conner, C., Weigel, R., Lal, G., Wolf, A., Liao, J. & Sugg, S. (2012). Referral Source and Outcomes of Patients with Nipple Discharge. ASBS 13th Annual Meeting.

Fang, L., Du, W., Yang, W., Rutnam, Z., Peng, C., Li, H., O'Malley, Y., Askeland, R., Sugg, S., Liu, M., Mehta, T., Deng, Z. & Yang, B. (2012). MiR-93 enhances angiogenesis and metastasis by targeting LATS2. Cell Cycle, 11(23), 4352-4365. PMID: 23111389.

Yan, X., Doffek, K., Yin, C., Krein, M., Phillips, M., Sugg, S., Johnson, B. & Shilyansky, J. (2012). Annexin-V promotes anti-tumor immunity and inhibits neuroblastoma growth in vivo. Cancer Immunology, Immunotherapy, 61(11), 1917-1927. PMID: 22476407.

O'Malley, Y., Lal, G., Howe, J., Weigel, R., Komorowski, R., Shilyansky, J. & Sugg, S. (2012). Invasion in follicular Thyroid Cancer (FTC) Cell Lines is Mediated by EphA2 and pAKT. Surgery, 152(6), 1218-1224. PMID: 23158188.

Doffek, K., Chen, X., Sugg, S. & Shilyansky, J. (2011). Phosphatidylserine inhibits NF?B and p38 MAPK activation in human monocyte derived dendritic cells. Molecular Immunology, 48(15-16), 1771-1777. PMID: 2168073.

Guidroz, J., Larrieux, G., Liao, J., Sugg, S., Scott-Conner, C. & Weigel, R. (2011). Sampling of secondary margins decreases the need for re-excision after partial mastectomy. Surgery, 150(4), 802-809. PMID: 22000194.

Spanheimer, P., Sugg, S., Lal, G., Howe, J. & Weigel, R. (2011). Surveillance and intervention following thyroid lobectomy. Annals of Surgical Oncology.

Cheng, G., Lopez, M., Zielonka, J., Hauser, A., Joseph, J., McAllister, D., Rowe, J., Sugg, S., Williams, C. & Kalyanaraman, B. (2011). Mitochondria-targeted nitroxides exacerbate fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells. (Vols. 12). (8) Cancer Biology & Therapy.

Gollapalli, V., Liao, J., Dudakovic, A., Sugg, S., Scott-Conner, C. & Weigel, R. (2010). Risk factors for development and recurrence of primary breast abscesses. 34th Annual Symposium of the American Society of Breast Disease.

Lal, G., Fairchild, T., Howe, J., Weigel, R., Sugg, S. & Menda, Y. (2010). PET-CT Scans in Recurrent or Persistent Differentiated Thyroid Cancer – Is there added utility beyond conventional imaging?. Surgery, 148(6), 1082-1089. PMID: 21134537.

Spanheimer, P., Sugg, S., Lal, G. & Weigel, R. (2010). Surveillance and intervention following thyroid lobectomy. American Association of Endocrine Surgeons.

Gollapalli, V., Liao, J., Dudakovic, A., Sugg, S., Scott-Conner, C. & Weigel, R. (2010). Risk factors for development and recurrence of primary breast abscesses. Journal of the American College of Surgeons, 211(1), 41-48. PMID: 20610247.

Gollapalli, V., Liao, J., Dudakovic, A., Sugg, S., Scott-Conner, C. & Weigel, R. (2010). Risk factors for development and recurrence of primary breast abscesses. National Consortium of Breast Centers Annual Meeting.

Lal, G., Fairchild, T., Howe, J., Weigel, R., Sugg, S. & Menda, Y. (2010). PET-CT Scans in Recurrent or Persistent Differentiated Thyroid Cancer – Is there added utility beyond conventional imaging?. American Association of Endocrine Surgeons.

Adamovic, T., McAllister, D., Wang, T., Adamovic, D., Rowe, J., Moreno, C., Lazar, J., Jacob, H. & Sugg, S. (2010). Identification of novel carcinogen-mediated mammary tumor susceptibility loci in the rat using the chromosome substitution technique. Genes, Chromoscomes, & Cancer, 49(11), 1035-1145. PMID: 20737482.

Fisher, C., Cole, D., Mitas, M., Garrett-Meyer, E., Metcalf, J., Gillanders, W., Mikhitarian, K., Urist, M., Mann, G., Doherty, G., Herrmann, V., Hill, A., Eremin, O., El-Sheemy, M., Orr, R., Valle, A., Henderson, M., Dewitty, R., Sugg, S., Frykberg, E., Yeh, K., Bell, R. & Baker, M. (2010). Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: a final analysis of a prospective multi-institutional cohort study. Annals of Surgical Oncology, 17(3), 312-320. PMID: 20853052.

Fang, S., Guidroz, J., O'Malley, Y., Lal, G., Sugg, S., Howe, J., Jensen, C. & Weigel, R. (2010). Expansion of a cell population expressing stem cell markers in parathyroid glands from patients with hyperparathyroidism. Annals of Surgery, 251(1), 107-113. PMID: 20009751.

Fang, S., Guidroz, J., O'Malley, Y., Lal, G., Sugg, S., Howe, J., Jensen, C. & Weigel, R. (2009). Expansion of a cell population expressing stem cell markers in parathyroid glands from patients with hyperparathyroidism. American Association of Endocrine Surgeons Annual Meeting poster presentation.

Spanheimer, P., Graham, M., Sugg, S., Scott-Conner, C. & Weigel, R. (2009). Measurement of uterine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy. Annals of Surgical Oncology, 16(5), 1176-1147. PMID: 19267158.

Lal, G., Nowell, A., Liao, J., Sugg, S., Weigel, R. & Howe, J. (2009). Determinants of survival in patients with calciphylaxis – a multivariate analysis. Surgery, 146(6), 1028-1034. PMID: 19958929.

Yen, T., Johnson, C. & Sugg, S. (2009). Surgery for Secondary and Tertiary Hyperparathyroidism: A) Secondary Hyperplasia, B)Tertiary Hyperplasia.

Johnson, M., Guidroz, J., Smith, B., Graham, M., Scott-Conner, C., Sugg, S. & Weigel, R. (2009). A single institutional experience of factors affecting successful identification of sentinel lymph node in breast cancer patients. Surgery, 146(4), 671-676. PMID: 19789026.

Lal, G., Nowell, A., Liao, J., Sugg, S., Weigel, R. & Howe, J. (2009). Determinants of survival in patients with calciphylaxis – a multivariate analysis. American Association of Endocrine Surgeons Annual Meeting.

Adamovic, T., McAllister, D., Guryev, V., Wang, X., Wendt Andrae, J., Cuppen, E., Jacob, H. & Sugg, S. (2009). Identification of microalterations affecting inherently unstable genomic regions in chemically induced rat mammary carcinomas as revealed by long oligonucleotide array-based Comparative Genomic Hybridization. Cancer Research, 69(12), 5159-5167.

Johnson, M., Guidroz, J., Smith, B., Graham, M., Scott-Conner, C., Sugg, S. & Weigel, R. (2009). A single institutional experience of factors affecting successful identification of sentinel lymph node in breast cancer patients. Central Surgical Association.

Calva, D., O'Dorisio, T., O'Dorisio, S., Lal, G., Sugg, S., Weigel, R. & Howe, J. (2009). When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?. Annals of Surgical Oncology, 16(8), 2237-2244. PMID: 19472011.

Wilson, S., Krzywda, E., Zhu, Y., Yen, T. & Sugg, S. (2008). The influence of surgery in MEN-1 syndrome: observations over 150 years. Central Surgical Association.

Wilson, S., Krzywda, E., Zhu, Y., Yen, T., Wang, T., Sugg, S. & Pappas, S. (2008). The influence of surgery in MEN-1 syndrome: observations over 150 years. Surgery, 144(4), 695-701. PMID: 18847656.

Adamovic, T., McAllister, D., Rowe, J., Wang, T., Jacob, H. & Sugg, S. (2008). Genetic mapping of mammary tumor traits to rat chromosome 10 using a novel panel of consomic rats. Cancer Genetics and Cytogenetics, 186(1), 41-48. PMID: 18786441.

Tallar, M., Yen, T., Kryzwda, E., Wilson, S. & Sugg, S. (2007). Incidental thyroid cancers are increasing-are they clinically significant?. The 2nd Academic Surgical Congress.

Shilyansky, J., Jacobs, P., Doffek, K. & Sugg, S. (2007). Induction of cytolytic T lymphocytes (CTL) against pediatric solid tumors in vitro using autologous DCs pulsed with necrotic primary tumor. Journal of Pediatric Surgery, 42(1), 54-61. PMID: 17208541.

Sinkevicius, K., Burdette, J., Woloszyn, K., Hewitt, S., Hamilton, K., Sugg, S., Temple, K., Wondisford, F., Korach, K., Woodruff, T. & Greene, G. (2007). An estrogen receptor a knock-in mutation provides evidence of ligand-independent signaling and allows modulation of ligand-induced pathways in vivo. Endocrinology, 149(6), 2970-2979. PMID: 18339713.

Shilyansky, J., Doffek, K., McAllister, D., Chen, X. & Sugg, S. (2006). PS inhibits DC maturation by interfering with P38 MAPK and NF-kappaB Signaling. 1st Annual Academic Surgical Congress. Published in the Journal for Surgical Research.

Shilyansky, J., Jacobs, P., Doffek, K. & Sugg, S. (2006). Induction of cytolytic T lymphocytes (CTL) against pediatric solid tumors in vitro using autologous DCs pulsed with necrotic primary tumor. Journal of Pediatric Surgery.

Sugg, S., McAllister, D., Komorowski, R., Rowe, J., Yen, T., Wilson, S. & Shilyansky, J. (2006). Targeting EphA2 inhibits invasiveness of thyroid cancer cells. American Association of Endocrine Surgeons 27th Annual Meeting.

Jayaraman, V., Yen, T., Krzywda, E., Wilson, S. & Sugg, S. (2006). Minimally invasive parathyroidectomy: How often is it possible?. American Association of Clinical Endocrinologists 15th Annual Meeting and Clinical Congress.

Shilyansky, J., Chen, X., Doffek, K. & Sugg, S. (2006). Neuroblastoma inhibit dendritic cell maturation by expressing phosphatidylserine on the cell surface. Proceedings of the American Association for Cancer Research.

Sugg, S., McAllister, D., Komorowski, R., Rowe, J., Yen, T., Wilson, S. & Shilyansky, J. (2006). Targeting EphA2 inhibits invasiveness of thyroid cancer cells. The Endocrine Society’s 2006 Annual Meeting “Endo 2006”.

Yen, T., Wilson, S., Krzywda, E. & Sugg, S. (2006). The role of parathyroid hormone (PTH) measurements after surgery for primary hyperparathyroidism. Surgery, 140(4), 665-672. PMID: 17011915.

Yen, T., Wilson, S., Krzywda, E. & Sugg, S. (2006). The role of parathyroid hormone (PTH) measurements after surgery for primary hyperparathyroidism. 63rd Annual Central Surgical Association meeting.

Sugg, S. (2006). Thyroid and Parathyroid. In M. Sabel , V. Sondak , J. Sussman (Eds.) Essentials of Surgical Oncology. Elsevier.

Balck, K., Krzywda, E., Sugg, S., Yen, T. & Wilson, S. (2006). Predictors of an elevated parathyroid (PTH) level after curative parathyroidectomy. American Association of Clinical Endocrinologists 15th Annual Meeting and Clinical Congress.

Lodge, A., Yu, P., Nicholl, M., Brown, I., Jackson, C., Schreiber, K., Sugg, S., Schreiber, H. & Shilyansky, J. (2006). CD40 ligation restores cytolytic T lymphocyte (CTL) response and eliminates murine fibrosarcoma in mice lacking CD4+ T cells. Cancer immunology Immunotherapy, 55(12), 1542-1552. PMID: 16491399.

Jayaraman, V., Yen, T., Sugg, S., Krzywda, E. & Wilson, S. (2005). Minimally invasive parathyroidectomy: How often is it possible? Is there too much hype?. Wisconsin Surgical Society – A Chapter of the American College of Surgeons Fall Meeting.

Sugg, S., McAllister, D., Komorowski, R., Hessner, M., Shilyansky, J., Yen, T. & Wilson, S. (2005). Use of Tissue Microarray to Evaluate Clinical Utility of Genes Overexpressed in a Metastatic Thyroid Cancer Cell Line. The Endocrine Society’s 87th Annual Meeting.

Balck, K., Krzywda, E., Sugg, S., Yen, T. & Wilson, S. (2005). Predictors of an elevated parathyroid (PTH) level after curative parathyroidectomy. Wisconsin Surgical Society – A Chapter of the American College of Surgeons Fall Meeting.

Bannister, K., Lodge, A., Sugg, S. & Shilyansky, J. (2004). Role of CTLA4 in tumor immunity. Annals of Surgical Oncology.

Nicholl, M., Lodge, A., Brown, I., Sugg, S. & Shilyansky, J. (2004). Restored immune response to an MHC-II-Restricted antigen in tumor-bearing hosts after elimination of regulatory T cells. Journal of Pediatric Surgery, 39(6), 941-946. PMID: 15185230.

Chen, X., Doffek, K., Sugg, S. & Shilyansky, J. (2004). Phosphatidylserine Regulates the Maturation of Human Dendritic Cells. Journal of Immunology, 173(5), 2985-2994. PMID: 15322157.

Doffek, K., Chen, X., Gavin, C., Sugg, S. & Shilyansky, J. (2004). PS modulates DC maturation and function by inhibiting ERK1/2, NFkB and p38 MAPK activation in response to LPS. International Proceedings of Immunology, 395-400.

Sugg, S., Krzywda, E., Demeure, M. & Wilson, S. (2004). Detection of multiple gland primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Presented at the 25th Annual Meeting of the American Association of Endocrine Surgeons,.

Aziz, R., Lodge, A., Chen, X., Sugg, S. & Shilyansky, J. (2004). Phosphatidylserine modulates the phenotype of mouse dendritic cells. Journal of the American College of Surgeons.

Hagos, F., Sugg, S., Fleming, G. & Olopade, O. Fluorescence in situ Hybridization (FISH) on Touch Preparation (TP) Slides: An efficient method to assess chromosome loss and Her2/neu Gene amplification in human breast cancer. (Vols. 41). pp. 181-200. Proc American Association for Cancer Research.

Scott-Conner, C., Dirksen, J. & Sugg, S. Fibrocystic breasts.

Sugg, S. Chemotherapy of cancer.

Doffek, K., Chen, X., Gavin, C., Sugg, S. & Shilyansky, J. (2004). Phosphatidylserine modulates DC maturation and function by inhibiting ERK1/2, NF?B and p38 MAPK activation in response to LPS. International Congress of Immunology.

Gavin, C., Doffek, K., Chen, X., Sugg, S. & Shilyansky, J. (2004). Downregulation of dendritic cell surface antigen expression and stimulatory function by apoptotic neutrophils is partly reversed by Annexin-V blockade. International Congress of Immunology.

Sugg, S., Krzywda, E., Demeure, M. & Wilson, S. (2004). Detection of multiple gland primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Surgery, 136(6), 1303-1309. PMID: 15657591.

Xiang, B., Du, L., Hessner, M., Jiang, N., Kappes, A., Shilyansky, J., Wilson, S. & Sugg, S. (2004). Comparison of metastatic vs primary follicular thyroid carcinoma call lines by cDNA microarray. Presented at The Endocrine Society's 86th Annual Meeting.

Xiang, B., Du, L., Hessner, M., Jiang, N., Kappes, A., Shilyansky, J., Demeure, M., Wilson, S. & Sugg, S. (2004). Altered gene expression in metastatic vs primary follicular thyroid carcinoma cell lines by cDNA mircroarray. New York, NY: Presented at The Society of Surgical Oncology Cancer Symposium.

Chen, X., Doffek, K., Gavin, C., Sugg, S. & Shilyansky, J. (2004). Immune evasion by Neuroblastoma (NB): Role of Phosphatidylserine (PS). Autumn Immunology Congress.

Gillanders, W., Mikhitarian, K., Hebert, R., Mauldin, P., Palesch, Y., Walters, C., Urist, M., Mann, G., Doherty, G., Hermann, V., Hill, A., Eremin, O., El-Sheemy, M., Orr, R., Valle, A., Henderson, M., Dewitty, R., Sugg, S., Frykberg, E., Yeh, K., Bell, R., Metcalf, J., Elliott, B., Brothers, T., Robison, J., Mitas, M. & Cole, D. (2004). Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Annals of Surgery, 239(6), 828-837. PMID: 15166962.

Shilyansky, J., Chen, X., Doffek, K. & Sugg, S. (2004). Phosphatidylserine modulated the maturation and function of human dendritic cells: A possible mechanism for immune evasion by Neuroblastoma. Keystone Symposia, Immune Evasion.

Shilyansky, J., Chen, X., Doffek, K. & Sugg, S. (2004). Phosphatidylserine modulated the maturation and function of human dendritic cells (DC): A mechanism for immune evasion by neuroblastoma (NB). American Association of Immunology/Experimental Biology. Published in FASEB Journal..

Doffek, K., Chen, X., Gavin, C., Sugg, S. & Shilyansky, J. (2004). Phosphatidylserine inhibits ERK1/2, NFkB and p38 MAPK but not AKT activation in response to LPS, modulating DC maturation and function. Autumn Immunology Congress.

Touzios, J., Kiely, J., Pitt, S., Rilling, W., Quebbeman, E., Sugg, S., Wilson, S. & Pitt, H. (2004). Neuroendocrine Hepatic Metastases: Does Aggressive Management Improve Survival?. Wisconsin Surgical Society.

Lodge, A., Yu, P., Brown, I., Sugg, S. & Shilyansky, J. (2003). Tumor elimination requires helper T cells for persistent CTL response. American College of Surgeons-Surgical Forum.

Krzywda, E., Touzios, J., Sugg, S., Adrian, M., Demeure, M., McCoy, R., Burgardt, L., Flood, E., Quiroz, F. & Wilson, S. (2003). A New Look at Parathyroid Imaging: Adding Ultrasound to Sestamibi Improves Preoperative Localization for Minimally Invasive Parathyroidectomy.

Chen, X., Doffek, K., Chan, E., Gavin, C., Sugg, S. & Shilyansky, J. (2003). Phosphatidylserine-dependent Suppression of dendritic cell function by Neuroblastoma: A novel mechanism of tumor evasion. Keystone Symposia. Journal of Immunotherapy.

Gillanders, W., Mikhitarian, K., Hebert, R., Mauldin, P., Palesch, Y., Walters, C., Urist, M., Mann, B., Doherty, G., Hermann, V., Hill, A., Eremin, O., El-Sheemy, M., Orr, R., Valle, A., Henderson, M., Adams-Campell, L., Sugg, S., Frykberg, E., Yeh, K., Bell, R., Metcalf, J., Elliott, B., Brothers, T., Robison, J., Mitas, M. & Cole, D. (2003). Molecular detection of micro-metastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: An interim analysis of a prospective multi-institutional cohort study. Southern Surgical Association.

Lodge, A., Yu, P., Brown, I., Sugg, S. & Shilyansky, J. (2003). Helper T cells are required for persistent CTL response and tumor elimination. American Association of Immunology.

Sugg, S., Li, J., Radek, J., Shilyansky, J. & Greene, F. (2003). Differences in Binding Affinity Causes Mutant Estrogen Receptor Alpha Ligand Discrimination. Proceedings of American Association of Cancer Research.

Touzios, J., Krzywda, E., Sugg, S., Adrian, M., Demeure, M., McCoy, R., Burgardt, L., Flood, E. & Wilson, S. (2003). A New Look at Parathyroid Imaging: Adding Ultrasound to Sestamibi Increases Accuracy for Minimally Invasive Parathyroidectomy. Presented to the Wisconsin Surgical Society.

Sugg, S., Krzywda, E., Adrian, M., Demeure, M. & Wilson, S. (2003). Multiple Gland Primary Hyperparathyroidism – The Achilles Heel of Focused Parathyroid Exploration. Presented to the Wisconsin Surgical Society.

Chen, X., Doffek, K., Sugg, S. & Shilyansky, J. (2003). Neuroblastoma cells inhibit the immunostimulatory function of dendritic cells. Journal of Pediatric Surgery, 38(6), 901-905. PMID: 12778389.

Sugg, S., Donegan, W. (2002). Staging and Prognosis.

Buell, J., Witteles, R., Koka, M., Sugg, S. & Kaplan, E. (2002). Neuroendocrine Tumors of the Pancreas.

Krzywda, E., Wilson, S., Sugg, S., O'Shaughnessy, I. & Hackbarth, I. (2002). Osteoitis Fibrosa Cystica and Primary Hyperparathyroidism – A Classic Disease. American College of Surgeons.

Hyngstrom, J., Jaskowiak, N., Sahoo, S., Recant, W., McBride, R., Heimann, R. & Sugg, S. (2002). Prognostic Value of Occult Metastases in Internal Mammary (IM) and Axillary (AX) in Breast Cancer. Society of Surgical Oncology.

Jaskowiak, N., Sugg, S., Helke, J., Koka, M. & Kaplan, E. (2002). Pitfalls of intraoperative quick parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism. Archives of Surgery, 137(6), 659-668. PMID: 12049636.

Sugg, S., Niu, Q., Dertz, S., Zimmerman, T. & Shilyansky, J. (2001). Detection of bone marrow micrometastases in advanced breast cancer using multiple genetic markers. American Association for Cancer Research.

Kaplan, E., Sugg, S. (2001). Surgery of the Thyroid Gland. In Endocrinology, 4th Edition. pp. 1567-1585. WB Saunders Co., Philadelphia.

Costa, E., Sugg, S. & Kaplan, E. (2001). Hyperthyroidism. In Surgical Endocrinology. pp. 21-36. Lippincott Williams & Wilkins, Philadelphia, PA.

Witteles, R., Strauss II, F., Sugg, S., Koka, M., Costa, E. & Kaplan, E. (2001). Adult nesidioblastosis causing hypoglycemia. An uncommon but important clinical entity. (Vols. 136). (6), pp. 656-663. Archives of Surgery. PMID: 11387003.

Sugg, S., Ferguson, D., Posner, M. & Heimann, R. (2000). Should internal mammary nodes be sampled in the sentinel lymph node era?. Annals of Surgical Oncology, 7(3), 188-192. PMID: 10791848.

Sugg, S., Litwin, D. (1999). Laparoscopic adrenalectomy: Endosurgery for Cancer. In Videoendoscopic Techniques and Cancer. RG Landes Biochemical Publishers, Austin, TX.

Soravia, C., Sugg, S., Berk, T., Mitri, A., Cheng, H., Gallinger, S., Cohen, Z., Asa, S. & Bapat, B. (1999). Familial adenomatous polyposis coli associated thyroid cancer: a clinical, pathological, and molecular genetic study. American Journal of Pathology, 54, 127-135.

Sugg, S., Ezzat, S., Zheng, L., Freeman, J., Rosen, I. & Asa, S. (1999). Oncogene profile of papillary thyroid carcinoma. Surgery, 125(1), 46-52. PMID: 9889797.

Kaplan, E., Sugg, S. & Costa, Jr, E. (1999). Thyroid Disease Manager.

Sugg, S., Ferguson, D., Posner, M. & Heimann, R. (1999). Should internal mammary nodes be sampled in the sentinel lymph node era?. Society for Surgical Oncology.

Sugg, S., Ezzat, S., Rosen, I., Freeman, J. & ASA, S. (1998). Distinct multiple ret/PTC gene rearrangements in multifocal papillary thyroid neoplasia. Journal of Clinical Endocrinology and Metabolism, 83(11), 4116-4122. PMID: 9814501.

Sugg, S., Zheng, L., Rosen, I., Freeman, J., Ezzat, S. & Asa, S. (1998). ErbB-2 Cytoplasmic staining but not mRNA levels correlate with differentiation in human thyroid neoplasm. Clinical Endocrinology, 49, 629-637.

Sugg, S., Ramyar, L., Rosen, I., Freeman, J., Ezzat, S. & Asa, S. (1997). Ret/PTC-1,2, & 3 oncogene rearrangements are more prevalent in occult than in clinical papillary thyroid carcinoma. 79th Annual Meeting of The Endocrine Society.

Sugg, S., Ramyar, L., Rosen, I., Freeman, J., Ezzat, S. & Asa, S. (1997). Ret/PTC oncogene rearrangements in multifocal papillary thyroid cancer: Evidence for discrete multicentric primary tumors. Annual Meeting of the Canadian Society of Surgical Oncology.

Sugg, S., Lange, J. & Fraker, D. (1997). CD 8+T cells mediates regression of EIA transfected murine sarcoma cells. Proceedings of American Association of Cancer Research.

Sugg, S., Zheng, L., Rosen, I., Freeman, J., Ezzat, S. & Asa, S. (1997). The c-erbB-2 proto-oncogene in human thyroid cancer: DNA amplification, quantative mRNA expression, immunohistochemistry and mutational analysis. Society of Cancer Research.

Sugg, S., Ramyar, L., Rosen, I., Ezzat, S. & Asa, S. (1997). Tumorigenesis in multifocal papillary thyroid carcinoma: Analysis by ret/PTC oncogene rearrangements.

Sugg, S., Zheng, L., Rosen, I., Freeman, J., Ezzat, S. & Asa, S. (1996). PTC/ret 1,2, & 3 expression in thyroid cancer. Cold Spring Harbor Laboratory Symposium on Cancer Genetics & Tumor Suppressor Genes.

Sugg, S., Zheng, L., Rosen, I., Freeman, J., Ezzat, S. & Asa, S. (1996). Ret/PTC-1,-2,-3 oncogene rearrangements in human thyroid carcinoma: implications for metastatic potential?. Journal of Clinical Endocrinology and Metabolism, 81(9), 3360-3365. PMID: 8784097.

Sugg, S., Zheng, L., Hosal, S., Rosen, I., Freeman, J., Ezzat, S. & Asa, S. (1996). Oncogene studies in human thyroid cancer. 4th International Conference on Neck & Neck Cancer.

Sugg, S., Zheng, L., Rosen, I., Freeman, J., Ezat, S. & Asa, S. (1996). PTC/ret 1,2, & 3 expression in thyroid cancer. 10th International Conference on Endocrinology.

Sugg, S., Gerndt, S., Hamilton, B., Francis, I., Taheri, P. & Rodriguez, J. (1995). Pseudoaneurysms of the intraparenchymal splenic artery following bunt abdominal trauma: A complication of nonoperative therapy and its management. Journal of Trauma, 39(3), 593-595. PMID: 7473932.

Norton, J., Sugg, S. (1995). Surgical Treatment of Hyperparathyroidism. In Endocrinology, 3rd edition. W.B. Saunders Co., Philadelphia, PA.

Sugg, S., Fraker, D., Alexander, R., Doppman, J., Miller, D., Chang, R., Skarulis, M., Marx, S., Spiegel, A. & Norton, J. (1993). Prospective evaluation of selective venous sampling for parathyroid hormone concentration in patients undergoing reoperations for primary hyperthyroidism. Surgery, 114(6), 1104-1009. PMID: 8256203.

Sugg, S., Norton, J., Fraker, D., Metz, D., Pisegna, J., Fishbeyn, V., Benya, R., Shawker, T., Doppman, J. & Jensen, R. (1993). A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas. Annals of Surgery, 218(2), 138-144.

Sugg, S., Fraker, D., Alexander, R., Doppman, J., Miller, D., Chang, R., Skarulis, M., Marx, S., Spiegel, A. & Norton, J. (1993). Prospective evaluation of selective venous sampling for parathyroid hormone concentration in patients undergoing reoperations for primary hyperthyroidism. American Association of Endocrine Surgeons.

Lenney, J., Liao, J., Sugg, S., Gopalakrishnan, V., Wong, H., Ouye, K. & Chan, P. (1982). Low molecular weight inhibitors of cathespsins B, H and T in human serum, synovial fluid and CSF. Biochemical & Biophysical Research Communications, 108(4), 1581-1587. PMID: 7181908.